Merck Fails To Nix Femina Birth Control Patent In ITC Row
Femina Pharma Inc. announced Wednesday that a U.S. International Trade Commission judge had rejected NuvaRing maker Merck & Co. Inc.'s claims that a Femina patent related to vaginal ring birth control...To view the full article, register now.
Already a subscriber? Click here to view full article